Earnings call transcript: Hudson Technologies Q1 2026 misses EPS forecast

Hudson Technologies reported Q1 2026 EPS of $0.01 versus $0.11 expected and revenue of $60.2 million versus $64.28 million expected, a sharp earnings miss despite 9% year-over-year revenue growth. Gross margin fell to 20% from 22% and SG&A rose to $9.5 million, mainly due to ERP implementation and strategic spending, though shares still rose 0.95% after hours to $6.35. Management kept a constructive full-year outlook, expecting gross margin recovery into Q2/Q3 and continued opportunistic buybacks.

Analysis

HDSN’s print looks worse than the headline suggests because the miss is primarily a timing/mixture issue rather than a demand collapse. The real risk is that management is leaning on “seasonality” to explain away a lower-margin product mix just as the business is simultaneously absorbing ERP friction; that combination can suppress operating leverage for multiple quarters if pricing normalizes faster than volumes accelerate. In other words, the market is being asked to underwrite a second-half margin rebound while also believing the new system is already fully functional — those two claims are directionally consistent, but not equally de-risked.

The second-order read-through is more interesting for adjacent refrigerant holders than for HDSN itself: if repair-over-replace is gaining traction because of supply uncertainty and higher feedstock costs, legacy HFC channels can hold up longer than consensus expects, while the replacement-product winners may see delayed monetization. That helps explain why the stock is not collapsing on a miss: investors are implicitly pricing the optionality of a stronger mid-year pricing environment and the possibility that reclaimed/recycled scarcity becomes more valuable if new supply is choppy. The flip side is that any sign of demand pull-forward into Q1 could leave Q2/Q3 less elastic than management implies.

Contrarian view: the consensus is probably over-focusing on gross-margin recovery and underweighting capital allocation. A sub-$300M market cap, net-cash balance sheet with active buybacks and strategic optionality makes downside less linear than a standard cyclical distributor; if execution stabilizes, repurchases at these levels can materially support EPS even without a big revenue re-acceleration. But if HFC pricing softens faster than expected, the buyback won’t save the multiple — the stock remains a trade on confidence in pricing discipline, not just on reported growth.

Key Decisions for Investors

• Long HDSN tactically into the next 4-8 weeks only on confirmation that Q2 pricing is firming and ERP-related SG&A stops rising; target 15-20% upside to the low/mid-$7s, but keep a tight stop if gross margin does not inflect sequentially.
• Buy HDSN Jan-2027 calls / sell nearer-dated calls to express the view that margin recovery is back-half weighted; risk/reward is attractive if the market starts discounting a mid-20s gross margin exit rate, but the position should be sized small because one more weak quarter can re-rate the stock lower.
• Pair trade: long HDSN / short a higher-beta industrial with unrelated margin risk over the next quarter to isolate refrigerant-price and capital-return optionality; use this only if you want event-driven alpha rather than broad market beta.
• Fade any spike in HDSN on warm-weather headlines unless channel checks confirm inventory rebuilding; the stock can overshoot on near-term volume optimism, but the sustainable move needs evidence that mix is not deteriorating again.
• Monitor CC and other chemical/feedstock-sensitive names for an indirect beneficiary setup if supply-chain uncertainty lifts legacy refrigerant demand, but treat it as a second-order trade until there is actual pricing pass-through evidence.